🇺🇸 FDA

Intelligence · Patent portfolio

Sunshine Guojian Pharmaceutical Patents

Full USPTO pharma patent portfolio for Sunshine Guojian Pharmaceutical — grant dates, expiration, and drug cross-links.

Patents
121
Expiring ≤24m
0

Quick answer

Sunshine Guojian Pharmaceutical has 121 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 3

  1. US 10501444

    Inhibitors of influenza virus replication, application methods and uses thereof

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10494364

    Cathepsin K inhibitors and application thereof

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10434131

    Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10370380

    Octahydropyrrolo[3,4-c]pyrrole derivatives and uses thereof

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10316025

    Substituted piperazine compounds and methods of use and use thereof

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10308658

    Salt of EGFR inhibitor, crystalline form and uses thereof

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10266521

    Substituted heteroaryl compounds and methods of use

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10266496

    Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10196383

    Substituted quinazoline compounds and preparation and uses thereof

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10183917

    Tricyclic compounds and uses thereof in medicine

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10179155

    Phosphodiesterase-4 inhibiting phytochemical compositions

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10149841

    Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof

    Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10100051

    Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10098889

    Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10065928

    Quinolinone compound and use thereof

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10065934

    Substituted urea derivatives and pharmaceutical uses thereof

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10059689

    Substituted heteroaryl compounds and methods of use

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9994566

    Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9974785

    Aromatic heterocyclic derivatives and pharmaceutical applications thereof

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9951010

    Compounds as CRTH2 antagonist and uses thereof

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9938257

    Substituted heteroaryl compounds and methods of use

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9926324

    Heteroaromatic compounds as PI3 kinase modulators and methods of use

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9920033

    Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9902712

    Nitrogenous heterocyclic derivatives and their application in drugs

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9884859

    Solid form of pyrazolopyridine compound

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9840482

    Sulfonamide derivatives and pharmaceutical applications thereof

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9828373

    2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9802949

    Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9771358

    Dihydropyrimidine compounds and their application in pharmaceuticals

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9738629

    Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9718841

    Bicyclic pyrazolone compounds and methods of use

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9714232

    Substituted piperazine compounds and methods of use thereof

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9695150

    Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9670194

    Substituted aminopyrimidine compounds and methods of use

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9663498

    Aromatic heterocyclic compounds and their application in pharmaceuticals

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9657007

    Substituted aminopyrimidine compounds and methods of use

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9598401

    Substituted heteroaryl compounds and methods of use thereof

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9598400

    Substituted quinoline compounds and methods of use

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9573953

    Heteroaromatic compounds as PI3 kinase modulators and methods of use

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9567300

    Hexahydropentaleno derivatives, preparation method and use in medicine thereof

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9556191

    Aminoquinazoline derivatives and their salts and methods of use thereof

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9518046

    Substituted aminopyrimidine compounds and methods of use

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9512114

    Substituted aminopyrimidine compounds and methods of use

    Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9498479

    Dihydropyrimidine compounds and their application in pharmaceuticals

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9434695

    Nitrogenous heterocyclic derivatives and their application in drugs

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9416139

    Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9403811

    Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9403801

    Substituted heteroaryl compounds and methods of use

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Sunshine Guojian Pharmaceutical have?

121 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Sunshine Guojian Pharmaceutical patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.